Supply Chain & Vendor Selection
Comparative evaluation of suppliers for your process - Enzymes, NTPs, plasmids, custom reagents and consumables. This includes assessment of cost, purity specifications, GMP compliance and known supply chain risks.
Single-Source Supply Chain Dependencies
The supply chain for critical inputs across these modalities—such as enzymes, nucleotides, and plasmids—is highly concentrated. Relying on a single vendor exposes manufacturing programs to severe supply disruptions or unexpected quality issues if a supplier changes their formulations, specifications, or manufacturing processes without notice.
Incomplete Technology Transfers (CDMO)
Transferring a manufacturing process to a CDMO without comprehensive documentation frequently leads to unreliable process reproduction. A successful transfer package must clearly define acceptable parameter ranges, critical material attributes, and explicitly outline known failure modes.
Equipment Incompatibility and Scale-Up Failures (CDMO)
Utilizing CDMO equipment that differs significantly from the original development site can trigger process deviations and necessitate costly, time-consuming bridging studies. Furthermore, failing to proactively identify and test how process parameters will behave at commercial volumes often results in failures during scaled-up production.
Let us help maximize your impact.
Smart molecule design is critical for execution!
Our strategy is built for robustness, success and speed. The correct design strategy saves time and decreases wet lab experiment design space, enables faster synthesis and scale up optimization to accelerate development freeing up your resources. Reduction of royalty and licensing costs and avoid common pitfalls. Reduced COGs and longer-term strategy baked in to ensure compliance with regulatory requirements.
Frequently Asked Questions
How do you help clients navigate complex supply chains?
We provide vendor-independent, technically rigorous guidance to successfully navigate the concentrated and opaque supply chains of nucleic acid and protein therapeutics.
What is included in your evaluation of critical raw material suppliers?
We conduct comparative evaluations of suppliers for components like enzymes, NTPs, plasmids, and custom reagents by thoroughly assessing their cost, purity specifications, GMP compliance, and known supply chain risks.
How do you protect programs against single-source supply risks?
We mitigate these vulnerabilities by designing multi-sourcing strategies specifically aimed at managing single-source risks for critical enzymes and reagents.